Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.
- Published In:
- Molecules (Basel, Switzerland), 24(18) (2019)
- Authors:
- Zhang, Xue, Lin, Congcong, Chan, Waikei, Liu, Kanglun, Lu, Aiping, Lin, Ge, Hu, Rong, Shi, Hongcan, Zhang, Hongqi, Yang, Zhijun
- Database ID:
- RPEP-04598
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04598APA
Zhang, Xue; Lin, Congcong; Chan, Waikei; Liu, Kanglun; Lu, Aiping; Lin, Ge; Hu, Rong; Shi, Hongcan; Zhang, Hongqi; Yang, Zhijun. (2019). Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.. Molecules (Basel, Switzerland), 24(18). https://doi.org/10.3390/molecules24183332
MLA
Zhang, Xue, et al. "Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice.." Molecules (Basel, 2019. https://doi.org/10.3390/molecules24183332
RethinkPeptides
RethinkPeptides Research Database. "Dual-Functional Liposomes with Carbonic Anhydrase IX Antibod..." RPEP-04598. Retrieved from https://rethinkpeptides.com/research/zhang-2019-dualfunctional-liposomes-with-carbonic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.